[18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status
乳腺癌
核医学
癌症
卵巢癌
医学
内科学
作者
Joanna K. Weeks,Austin R. Pantel,Sarah B. Gitto,Fang Liu,Erin K. Schubert,Daniel A. Pryma,Michael D. Farwell,David A. Mankoff,Robert H. Mach,Fiona Simpkins,Lilie L. Lin
Poly(adenosine diphosphate-ribose) polymerase-1 (PARP1) inhibitors have improved ovarian cancer treatment outcomes. However, clinical response remains heterogeneous. Existing biomarkers, mainly breast cancer susceptibility genes 1 and 2 (
PDF的下载单位、IP信息已删除
(2025-6-4)
科研通AI6.2
lizishu
热心市民小红花
嘿嘿
Criminology34
Mic
ltt
Twonej
MM
ceeray23
稳重的蛟凤
机灵柚子
无极微光
GeoEye
乐空思
wbqdssl
科研狗
殷勤的紫槐
yznfly
Wind
bravo
魏青瑜
Okra
舒心的雍
皖公网安备34019202002308
